↓ Skip to main content

Dopamine agents for hepatic encephalopathy

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter
1 tweeter
peer_reviews
1 peer review site

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dopamine agents for hepatic encephalopathy
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd003047.pub3
Pubmed ID
Authors

Anders Ellekaer Junker, Bodil Als-Nielsen, Christian Gluud, Lise Lotte Gluud

Abstract

Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 19%
Student > Bachelor 13 18%
Student > Ph. D. Student 9 13%
Researcher 7 10%
Other 6 8%
Other 10 14%
Unknown 13 18%
Readers by discipline Count As %
Medicine and Dentistry 29 40%
Psychology 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Nursing and Health Professions 4 6%
Neuroscience 2 3%
Other 10 14%
Unknown 17 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2020.
All research outputs
#9,386,185
of 15,986,297 outputs
Outputs from Cochrane database of systematic reviews
#9,264
of 11,349 outputs
Outputs of similar age
#90,481
of 195,588 outputs
Outputs of similar age from Cochrane database of systematic reviews
#188
of 216 outputs
Altmetric has tracked 15,986,297 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,349 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.6. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,588 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.